Clinical Trial

Reverse T-stenting and Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation

Study acronym: T-REX
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 19, 2023 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The Reverse T-stenting And Minimal Protrusion (Reverse TAP) is an up-front 2-stent technique that treats complex coronary bifurcation. Compared to crush techniques, it does not require crushing of the side branch stent but only minimal protrusion of the side branch stent before main vessel stenting. Nowadays, no studies compare the Reverse-TAP and the External Minicrush in treating complex coronary bifurcation, so eventually, procedural, clinical and safety differences remain unknown.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-03-22.
Trial Details
NCT Number NCT05782738
Lead Sponsor San Luigi Gonzaga Hospital
Conditions Coronary Artery Disease, Coronary Stenosis, Coronary Disease
Enrollment 361 participants
Start Date 2023-06-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2023-04-19